Patent ID: 7455995
Filing Date: 2008-11-25
Classification: C12Q,G01N

Abstract:
1. A method for characterizing acute myelogenous leukemia (AML) in a patient with AML, comprising assaying for overexpression of one or more BAALC transcripts in cells obtained from the patient, wherein the BAALC transcripts are selected from the group consisting of transcripts identified as 1-8, 1-6-8, 1-5-6-8, 1-4-5-6-8, 1-5-6-7-8, 1-2-6-8, 1-2-5-6-8, and 1-2-3-6-8; and wherein overexpression of one or more of the BAALC transcripts in cells of the patient indicates that the patient has an aggressive form of AML.